Biopac India Corporation Ltd. - Research Center
532330 BIOPAC Group (XT) BSE data
Results
Statement
More
Mar ' 20 |
Mar ' 19 |
Mar ' 18 |
Mar ' 17 |
Mar ' 16 |
Equity share capital
17.25 |
17.25 |
17.25 |
17.25 |
17.25 |
Share application money
Preference share capital
Reserves & surplus
-33.93 |
-22.84 |
0.28 |
2.98 |
2.88 |
Secured loans
29.75 |
24.68 |
33.29 |
23.24 |
23.44 |
Unsecured loans
Total
13.07 |
19.09 |
50.81 |
43.47 |
44.97 |
Gross block
23.31 |
47.20 |
47.04 |
51.91 |
96.30 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
23.31 |
36.37 |
41.62 |
46.51 |
50.50 |
Capital work-in-progress
Investments
Current assets, loans & advances
0.63 |
7.51 |
23.47 |
13.43 |
11.01 |
Less : current liabilities & provisions
10.87 |
24.79 |
14.28 |
16.47 |
16.54 |
Total net current assets
-10.24 |
-17.28 |
9.19 |
-3.04 |
-5.53 |
Miscellaneous expenses not written
Total
13.07 |
19.09 |
50.81 |
43.47 |
44.97 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
172.50 |
172.50 |
172.50 |
172.50 |
172.50 |